CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: alkaloid
Accession: CHEBI:22315
browse the term
Definition: Any of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
Synonyms: exact_synonym: alkaloids
related_synonym: Alkaloide; alcaloide; alcaloides
alt_id: MESH:D000470
xref_mesh: MESH:D000470
xref: Wikipedia:Alkaloid
G
AMBP
alpha-1-microglobulin/bikunin precursor
decreases uptake
EXP
Colchicine results in decreased uptake of AMBP protein
CTD
PMID:9019736
NCBI chr 1:254,683,885...254,703,220
Ensembl chr 1:254,683,891...254,703,225
G
ADCYAP1
adenylate cyclase activating polypeptide 1
multiple interactions
EXP
Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein]
CTD
PMID:28506824
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,631...105,422,294
G
ADCYAP1R1
ADCYAP receptor type I
decreases expression
EXP
Nicotine results in decreased expression of ADCYAP1R1 protein
CTD
PMID:28506824
NCBI chr18:41,915,180...41,972,327
Ensembl chr18:41,917,428...41,972,301
G
AMH
anti-Mullerian hormone
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of AMH mRNA Nicotine results in decreased secretion of AMH protein
CTD
PMID:32423882
NCBI chr 2:76,415,564...76,418,315
Ensembl chr 2:76,414,427...76,418,312
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
Nicotine results in decreased expression of BCL2 mRNA
CTD
PMID:32423882
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
CHRNA2
cholinergic receptor nicotinic alpha 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein]
CTD
PMID:28235547
NCBI chr14:11,193,732...11,204,334
Ensembl chr14:11,195,228...11,207,650
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein]
CTD
PMID:28235547
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,899...47,384,303
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein]
CTD
PMID:28235547
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CHRNA9
cholinergic receptor nicotinic alpha 9 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein]
CTD
PMID:28235547
NCBI chr 8:31,430,933...31,456,385
Ensembl chr 8:31,443,043...31,456,384
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein]
CTD
PMID:28235547
NCBI chr 4:95,196,992...95,211,084
Ensembl chr 4:95,198,717...95,211,037
G
CYP19A3
cytochrome P450 19A3
decreases expression
EXP
Nicotine results in decreased expression of CYP19A1 mRNA
CTD
PMID:32423882
NCBI chr 1:120,476,890...120,556,103
Ensembl chr 1:120,367,667...120,695,899
G
FSHR
follicle stimulating hormone receptor
decreases expression
EXP
Nicotine results in decreased expression of FSHR mRNA
CTD
PMID:32423882
NCBI chr 3:91,607,236...91,775,255
Ensembl chr 3:91,607,305...91,774,683
G
INHBB
inhibin subunit beta B
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of INHBB mRNA Nicotine results in decreased secretion of INHBB protein
CTD
PMID:32423882
NCBI chr15:30,999,994...31,004,405
Ensembl chr15:30,999,520...31,004,405
G
ITGB1
integrin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of ITGB1 mRNA
CTD
PMID:32423882
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of LAMB1 mRNA
CTD
PMID:32423882
NCBI chr 9:107,670,120...107,747,242
Ensembl chr 9:107,671,152...107,772,269
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK1 protein Nicotine results in decreased expression of MAPK1 mRNA
CTD
PMID:32423882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK3 protein Nicotine results in decreased expression of MAPK3 mRNA
CTD
PMID:32423882
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPK8
mitogen-activated protein kinase 8
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK8 protein Nicotine results in decreased expression of MAPK8 mRNA
CTD
PMID:32423882
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
G
MMP9
matrix metallopeptidase 9
increases expression
EXP
Nicotine results in increased expression of MMP9 mRNA
CTD
PMID:32423882
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
OCLN
occludin
decreases expression
EXP
Nicotine results in decreased expression of OCLN mRNA
CTD
PMID:32423882
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
Nicotine results in decreased expression of RPP38 mRNA
CTD
PMID:32423882
NCBI chr10:46,720,135...46,725,962
Ensembl chr10:46,717,197...46,725,920
G
CSNK1A1
casein kinase 1 alpha 1
decreases activity affects activity
EXP
Ageladine A analog results in decreased activity of CSNK1A1 protein Ageladine A affects the activity of CSNK1A1 protein
CTD
PMID:21413800
NCBI chr 2:150,612,845...150,662,431
Ensembl chr 2:150,612,077...150,662,284
G
FN1
fibronectin 1
multiple interactions increases expression
EXP
pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of FN1 protein]
CTD
PMID:26908192
NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014
G
SERPINE1
serpin family E member 1
increases expression multiple interactions
EXP
Arecoline results in increased expression of SERPINE1 protein pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of SERPINE1 protein]
CTD
PMID:26908192
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
TGFB1
transforming growth factor beta 1
multiple interactions increases expression
EXP
Arecoline results in increased secretion of and results in increased activity of TGFB1 protein; pyrazolanthrone inhibits the reaction [Arecoline results in increased expression of TGFB1 mRNA]
CTD
PMID:26908192
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
CHRM2
cholinergic receptor muscarinic 2
multiple interactions
EXP
brucine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein]
CTD
PMID:12757728
NCBI chr18:12,455,139...12,600,314
Ensembl chr18:12,455,145...12,600,186
G
RYR1
ryanodine receptor 1
increases activity multiple interactions
EXP
Caffeine results in increased activity of RYR1 protein; Caffeine results in increased activity of RYR1 protein mutant form Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein mutant form]; Dantrolene inhibits the reaction [Caffeine results in increased activity of RYR1 protein]
CTD
PMID:11278295
NCBI chr 6:47,339,759...47,458,457
Ensembl chr 6:47,343,768...47,458,458
G
EDN1
endothelin 1
increases expression multiple interactions
EXP
Cocaine results in increased expression of EDN1 protein 1,3-ditolylguanidine inhibits the reaction [Cocaine results in increased expression of EDN1 protein]; Haloperidol inhibits the reaction [Cocaine results in increased expression of EDN1 protein]
CTD
PMID:9714087
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
ALB
albumin
decreases uptake
EXP
cylindrospermopsin results in decreased uptake of ALB protein
CTD
PMID:33689780
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
increases expression
EXP
cylindrospermopsin results in increased expression of ATP1A1 mRNA
CTD
PMID:33689780
NCBI chr 4:104,353,506...104,384,321
Ensembl chr 4:104,353,508...104,384,547
G
DAB2
DAB adaptor protein 2
decreases expression
EXP
cylindrospermopsin results in decreased expression of DAB2 mRNA
CTD
PMID:33689780
NCBI chr16:24,590,638...24,776,937
Ensembl chr16:24,590,645...24,646,122
G
LRP2
LDL receptor related protein 2
decreases expression
EXP
cylindrospermopsin results in decreased expression of LRP2 mRNA
CTD
PMID:33689780
NCBI chr15:75,565,299...75,754,604
Ensembl chr15:75,565,303...75,716,694
G
CHRM4
cholinergic receptor muscarinic 4
multiple interactions
EXP
himbacine inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM4 protein]
CTD
PMID:8744975
NCBI chr 2:16,119,794...16,131,080
Ensembl chr 2:16,122,704...16,130,810
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of AKT1 protein]
CTD
PMID:37120089
G
ARB2A
ARB2 cotranscriptional regulator A
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ARB2A mRNA]
CTD
PMID:37120089
NCBI chr 2:100,477,770...100,893,594
Ensembl chr 2:100,477,775...100,893,580
G
ATG5
autophagy related 5
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in increased expression of ATG5 protein]
CTD
PMID:37120089
NCBI chr 1:72,343,950...72,520,402
Ensembl chr 1:72,270,799...72,520,396
G
BAX
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of BAX protein]
CTD
PMID:35665993
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCL2
BCL2 apoptosis regulator
multiple interactions increases expression
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [Malathion results in decreased expression of BCL2 mRNA] Melatonin results in increased expression of BCL2 mRNA
CTD
PMID:31535366 PMID:37120089
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BECN1
beclin 1
increases expression multiple interactions
EXP
Melatonin results in increased expression of BECN1 protein Melatonin inhibits the reaction [deoxynivalenol results in increased expression of BECN1 protein]
CTD
PMID:37120089
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
CASP3
caspase 3
decreases expression multiple interactions
EXP
Melatonin results in decreased expression of CASP3 mRNA Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP3 protein]
CTD
PMID:31535366 PMID:35665993
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in decreased expression of CASP8 protein]
CTD
PMID:35665993
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of CASP9 protein]
CTD
PMID:35665993
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAT
catalase
multiple interactions increases activity
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased activity of CAT protein]; Melatonin inhibits the reaction [Malathion results in decreased expression of CAT mRNA] Melatonin results in increased activity of CAT protein
CTD
PMID:31535366 PMID:37120089
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CHUK mRNA]
CTD
PMID:37120089
NCBI chr14:111,316,178...111,351,669
Ensembl chr14:111,315,141...111,351,868
G
CLDN1
claudin 1
multiple interactions increases expression
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] Melatonin results in increased expression of CLDN1 protein
CTD
PMID:37120089
NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657
G
COX7A2L
cytochrome c oxidase subunit 7A2 like
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of COX7A2L mRNA]
CTD
PMID:35665993
NCBI chr 3:97,951,115...97,983,309
Ensembl chr 3:97,951,114...97,983,309
G
GPX4
glutathione peroxidase 4
increases expression
EXP
Melatonin results in increased expression of GPX4 mRNA
CTD
PMID:31535366
NCBI chr 2:77,321,568...77,323,931
Ensembl chr 2:77,320,464...77,323,931
G
IL18
interleukin 18
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL18 mRNA]
CTD
PMID:37120089
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL6
interleukin 6
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]
CTD
PMID:37120089
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
KLF5
KLF transcription factor 5
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of KLF5 mRNA]
CTD
PMID:37120089
NCBI chr11:45,370,009...45,386,673
Ensembl chr11:45,369,810...45,388,314
G
LOC110258578
interleukin-1 beta-like
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]
CTD
PMID:37120089
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
multiple interactions
EXP
Melatonin affects the reaction [deoxynivalenol results in increased expression of and results in increased lipidation of MAP1LC3B protein]
CTD
PMID:37120089
NCBI chr 6:1,919,879...1,941,069
Ensembl chr 6:1,915,387...1,941,069
G
MAP2K1
mitogen-activated protein kinase kinase 1
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of MAP2K1 mRNA]
CTD
PMID:37120089
NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
G
MLKL
mixed lineage kinase domain like pseudokinase
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of MLKL protein]
CTD
PMID:35665993
NCBI chr 6:12,923,846...12,951,176
Ensembl chr 6:12,924,894...12,951,173
G
MTOR
mechanistic target of rapamycin kinase
multiple interactions decreases phosphorylation
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased phosphorylation of MTOR protein] Melatonin results in decreased phosphorylation of MTOR protein
CTD
PMID:37120089
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
OCLN
occludin
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein]
CTD
PMID:37120089
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033
G
PLIN2
perilipin 2
multiple interactions
EXP
Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 protein]
CTD
PMID:31535366
NCBI chr 1:203,683,867...203,709,277
Ensembl chr 1:203,683,862...203,709,273
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions
EXP
Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein]
CTD
PMID:31535366
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
PTEN
phosphatase and tensin homolog
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of PTEN protein]
CTD
PMID:35665993
NCBI chr14:99,929,590...100,021,619
G
RIPK1
receptor interacting serine/threonine kinase 1
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK1 protein]
CTD
PMID:35665993
NCBI chr 7:1,841,143...1,880,705
Ensembl chr 7:1,841,239...1,880,699
G
RIPK3
receptor interacting serine/threonine kinase 3
multiple interactions
EXP
Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 mRNA]; Melatonin inhibits the reaction [tetrabromobisphenol A results in increased expression of RIPK3 protein]
CTD
PMID:35665993
NCBI chr 7:74,951,145...74,955,255
Ensembl chr 7:74,951,145...74,955,251
G
SOD2
superoxide dismutase 2
increases expression multiple interactions
EXP
Melatonin results in increased expression of SOD2 mRNA Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of SOD2 mRNA]
CTD
PMID:31535366 PMID:37120089
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
TJP1
tight junction protein 1
increases expression multiple interactions
EXP
Melatonin results in increased expression of TJP1 protein Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]
CTD
PMID:37120089
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836
G
TNF
tumor necrosis factor
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]
CTD
PMID:37120089
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TP53
tumor protein p53
multiple interactions decreases expression
EXP
Melatonin inhibits the reaction [Malathion results in increased expression of TP53 mRNA] Melatonin results in decreased expression of TP53 mRNA
CTD
PMID:31535366
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
ZFP36L2
ZFP36 ring finger protein like 2
multiple interactions
EXP
Melatonin inhibits the reaction [deoxynivalenol results in decreased expression of ZFP36L2 mRNA]
CTD
PMID:37120089
NCBI chr 3:97,200,395...97,203,094
Ensembl chr 3:97,200,407...97,204,698
G
HTR2C
5-hydroxytryptamine receptor 2C
affects binding multiple interactions
EXP
mesulergine binds to HTR2C protein 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine inhibits the reaction [mesulergine binds to HTR2C protein]
CTD
PMID:11927170
NCBI chr X:94,053,415...94,313,352
Ensembl chr X:94,053,456...94,313,355
G
ODC1
ornithine decarboxylase 1
increases activity increases expression
EXP
Monocrotaline results in increased activity of ODC1 protein Monocrotaline results in increased expression of ODC1 mRNA
CTD
PMID:9812344
NCBI chr 3:126,087,013...126,095,644
Ensembl chr 3:126,087,242...126,096,051
G
TNC
tenascin C
multiple interactions increases expression
EXP
1,3-dimethylthiourea inhibits the reaction [Monocrotaline results in increased expression of TNC mRNA]
CTD
PMID:9251245
NCBI chr 1:255,533,235...255,630,381
Ensembl chr 1:255,533,238...255,630,376
G
FOXO1
forkhead box O1
increases expression
EXP
Niacinamide results in increased expression of FOXO1 mRNA
CTD
PMID:17851734
NCBI chr11:15,317,222...15,410,059
Ensembl chr11:15,317,124...15,410,473
G
PPARG
peroxisome proliferator activated receptor gamma
increases expression
EXP
Niacinamide results in increased expression of PPARG mRNA
CTD
PMID:17851734
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
SIRT1
sirtuin 1
decreases expression
EXP
Niacinamide results in decreased expression of SIRT1 mRNA
CTD
PMID:17851734
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
ADCYAP1
adenylate cyclase activating polypeptide 1
multiple interactions
EXP
Nicotine inhibits the reaction [[Carbon Dioxide co-treated with Oxygen deficiency] results in decreased expression of ADCYAP1 protein]
CTD
PMID:28506824
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,631...105,422,294
G
ADCYAP1R1
ADCYAP receptor type I
decreases expression
EXP
Nicotine results in decreased expression of ADCYAP1R1 protein
CTD
PMID:28506824
NCBI chr18:41,915,180...41,972,327
Ensembl chr18:41,917,428...41,972,301
G
AMH
anti-Mullerian hormone
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of AMH mRNA Nicotine results in decreased secretion of AMH protein
CTD
PMID:32423882
NCBI chr 2:76,415,564...76,418,315
Ensembl chr 2:76,414,427...76,418,312
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
Nicotine results in decreased expression of BCL2 mRNA
CTD
PMID:32423882
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
CHRNA2
cholinergic receptor nicotinic alpha 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA2 protein]
CTD
PMID:28235547
NCBI chr14:11,193,732...11,204,334
Ensembl chr14:11,195,228...11,207,650
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA3 protein]
CTD
PMID:28235547
NCBI chr 7:47,361,710...47,382,743
Ensembl chr 7:47,361,899...47,384,303
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA7 protein]
CTD
PMID:28235547
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CHRNA9
cholinergic receptor nicotinic alpha 9 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNA9 protein]
CTD
PMID:28235547
NCBI chr 8:31,430,933...31,456,385
Ensembl chr 8:31,443,043...31,456,384
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
multiple interactions
EXP
Nicotine affects the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] affects the expression of CHRNB2 protein]
CTD
PMID:28235547
NCBI chr 4:95,196,992...95,211,084
Ensembl chr 4:95,198,717...95,211,037
G
CYP19A3
cytochrome P450 19A3
decreases expression
EXP
Nicotine results in decreased expression of CYP19A1 mRNA
CTD
PMID:32423882
NCBI chr 1:120,476,890...120,556,103
Ensembl chr 1:120,367,667...120,695,899
G
FSHR
follicle stimulating hormone receptor
decreases expression
EXP
Nicotine results in decreased expression of FSHR mRNA
CTD
PMID:32423882
NCBI chr 3:91,607,236...91,775,255
Ensembl chr 3:91,607,305...91,774,683
G
INHBB
inhibin subunit beta B
decreases expression decreases secretion
EXP
Nicotine results in decreased expression of INHBB mRNA Nicotine results in decreased secretion of INHBB protein
CTD
PMID:32423882
NCBI chr15:30,999,994...31,004,405
Ensembl chr15:30,999,520...31,004,405
G
ITGB1
integrin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of ITGB1 mRNA
CTD
PMID:32423882
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
Nicotine results in decreased expression of LAMB1 mRNA
CTD
PMID:32423882
NCBI chr 9:107,670,120...107,747,242
Ensembl chr 9:107,671,152...107,772,269
G
MAPK1
mitogen-activated protein kinase 1
decreases expression decreases phosphorylation
EXP
Nicotine results in decreased expression of MAPK1 mRNA Nicotine results in decreased phosphorylation of MAPK1 protein
CTD
PMID:32423882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation decreases expression
EXP
Nicotine results in decreased phosphorylation of MAPK3 protein Nicotine results in decreased expression of MAPK3 mRNA
CTD
PMID:32423882
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPK8
mitogen-activated protein kinase 8
decreases expression decreases phosphorylation
EXP
Nicotine results in decreased expression of MAPK8 mRNA Nicotine results in decreased phosphorylation of MAPK8 protein
CTD
PMID:32423882
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
G
MMP9
matrix metallopeptidase 9
increases expression
EXP
Nicotine results in increased expression of MMP9 mRNA
CTD
PMID:32423882
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
OCLN
occludin
decreases expression
EXP
Nicotine results in decreased expression of OCLN mRNA
CTD
PMID:32423882
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
Nicotine results in decreased expression of RPP38 mRNA
CTD
PMID:32423882
NCBI chr10:46,720,135...46,725,962
Ensembl chr10:46,717,197...46,725,920
G
ACHE
acetylcholinesterase
decreases activity multiple interactions
EXP
Physostigmine results in decreased activity of ACHE protein Physostigmine inhibits the reaction [Soman results in decreased activity of ACHE protein]
CTD
PMID:21414391
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
RYR1
ryanodine receptor 1
affects binding multiple interactions
EXP
Ryanodine binds to RYR1 protein; Ryanodine binds to RYR1 protein mutant form 5'-adenylyl (beta,gamma-methylene)diphosphonate affects the reaction [Ryanodine binds to RYR1 protein]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein mutant form]]; Dantrolene inhibits the reaction [Caffeine promotes the reaction [Ryanodine binds to RYR1 protein]]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein mutant form]; Dantrolene inhibits the reaction [Ryanodine binds to RYR1 protein]; Dantrolene inhibits the reaction [Strontium promotes the reaction [Ryanodine binds to RYR1 protein]]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein mutant form]; Strontium promotes the reaction [Ryanodine binds to RYR1 protein]
CTD
PMID:11278295
NCBI chr 6:47,339,759...47,458,457
Ensembl chr 6:47,343,768...47,458,458
G
RYR2
ryanodine receptor 2
affects binding
EXP
Ryanodine binds to RYR2 protein
CTD
PMID:11278295
NCBI chr14:53,652,140...54,406,691
Ensembl chr14:53,652,485...54,192,063
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
EXP
Serotonin results in increased expression of FOS mRNA; Serotonin results in increased expression of FOS protein sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein]
CTD
PMID:11426759
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
EXP
sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein] Serotonin results in increased expression of JUN mRNA; Serotonin results in increased expression of JUN protein
CTD
PMID:11426759
NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation multiple interactions
EXP
Serotonin results in increased phosphorylation of MAPK1 protein sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:11426759
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
EXP
sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11426759
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
CHRM2
cholinergic receptor muscarinic 2
multiple interactions
EXP
Strychnine analog promotes the reaction [N-Methylscopolamine binds to CHRM2 protein]
CTD
PMID:12757728
NCBI chr18:12,455,139...12,600,314
Ensembl chr18:12,455,145...12,600,186
G
TAC1
tachykinin precursor 1
affects activity
EXP
Tubocurarine affects the activity of TAC1 protein
CTD
PMID:11877319
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
5066
role
5030
biological role
5030
biochemical role
4951
metabolite
4939
alkaloid
74
(+)-Aspidospermidine
0
(+)-Erythraline
0
(+)-Norushinsunine N-oxide
0
(+)-Quebrachidine
0
(+)-Setoclavine
0
(+)-aplysinillin
0
(+/-)-gamma-Lycorane
0
(-)-12beta-Hydroxylsophocarpine
0
(-)-Alstolucine A, (rel)-
0
(-)-Alstolucine B, (rel)-
0
(-)-Alstolucine C
0
(-)-Alstolucine D, (rel)-
0
(-)-Alstolucine E
0
(-)-Alstolucine F
0
(-)-Apparicine
0
(-)-Ormosanine
0
(-)-Pyrifolidine
0
(-)-Quebrachamine
0
(-)-antofine
0
(-)-demecolcine
0
(-)-dibromophakellin
0
(13R,14E)-14-Ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene
0
(1R,1'R,10S,11S,12S,13'S,14'R)-12,14'-Diethylspiro[8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,8-tetraene-10,10'-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,12(21)-tetraene]
0
(1R,13S,14E,19S,21S)-10-[(1R,12S,13R,14E,17R,19S,21S)-14-Ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-14-(2-hydroxyethylidene)-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,11-tetraen-9-one
0
(1R,15R,17S)-17-Ethyl-6-[(1R,14R,15E)-15-ethylidene-17,18-dimethyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene
0
(1R,2R,12R,14S)-9-Methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraene-2,14-diol
0
(1R,2S,6S,11S,13R,14R,21R)-7,19,23-Triazahexacyclo[9.9.1.11,13.12,6.07,21.014,19]tricosane
0
(1R,9R)-5-Cyclohexyl-11-(propylsulfonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one
0
(1S,15S,18S,19S,20S)-N-[2-(4-aminophenyl)ethyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
0
(1S,9R,10R,12S)-12-Hydroxy-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4-dien-6-one
0
(2'S)-Hydroxy-(11S,12R)-dihydrostemofoline, (rel)-
0
(2'S)-Hydroxystemofoline
0
(2R,3R,11Bs)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinoline
0
(2R,3S,11bR)-2-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(2S,3R)-2-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(2S,3R)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(4aR,5aS,8aR,15bR)-10,11-dimethoxy-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one
0
(4aR,8aR,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one
0
(7S)-7-acetamido-1,2,3-trimethoxy-6,7-dihydro-5H-dibenzo[5,3-b:1',2'-e][7]annulene-9-carboxylic acid
0
(7S,14S)-(-)-7-Methyl-10-O-demethylxylopinine
0
(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethylhept-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol
0
(E)-Avenanthramide D
0
(R,S)-Scoulerine
0
(S)-1-hydroxy-N-methylcanadine +
0
(S)-colchicine
1
1',2'-didehydrostemofoline
0
1,2-O-Diacetylzephyranthine
0
1-O-Acetyllycorine
0
1-[(1R,9S,11R,12E,17S)-12-Ethylidene-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6-trien-8-yl]ethanone
0
1-hydroxyprotostemonine, (rel)-
0
1-methoxy-5R,10S-agroclavine
0
10-alpha-methoxy-9,10-dihydrolysergol
0
11-(Methylthiono)canthin-6-one
0
11-Hydroxytubotaiwine
0
11-Hydroxyvittatine
0
11-Methoxyduguesuramine
0
11-Methoxysampangine
0
11-beta-hydroxy-beta-saxitoxinol(2+)
0
11-beta-hydroxysaxitoxin(2+)
0
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
0
13-O-Acetylbaptifoline
0
13-Oxocryptopine
0
14,15-Dehydro-16-epi-vincamine
0
14,19-Didehydrocondyfolan
0
14,19-Dihydroaspidospermatine
0
14-norpseurotin A
0
15-hydroxyangustilobine A
0
16-Ethoxystrychnine
0
16-Propoxystrychnine
0
16-epivincamine
0
16R,19E-isositsirikine
0
18-Epiormosanine
0
18-Hydroxy-11,17-dimethoxyyohimban-16-carboxylic acid
0
19,20-E-vallesamine
0
19-Acetyltabersonine
0
19-Hydroxytabersonine
0
2'-hydroxystemofoline
0
2,3,9,10-Tetrahydroxyberberine
0
2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline
0
2-(8-Oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)acetamide
0
2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide
0
2-Methoxycanthin-6-one
0
2-\{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino\}-5-hydroxybenzoic acid
0
2-phenylethylamine +
0
2-propylpiperidine
0
20(R)-tubotaiwine
0
20(S)-tubotaiwine
0
20-Epi-19,20-dihydro-decarbomethoxy vobasine
0
2alpha-(2'-pyrrolyl)-4alpha-methoxycarbonyl-5beta-[(2''-methyl)-heptyl]-1,3-oxazacyclohexane
0
3,4-dimethoxyphenylethylamine
0
3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol
0
3-(4-methoxyphenyl)-3-[[2-(4-methoxyphenyl)-1-oxoethyl]amino]propanoic acid
0
3-(6-chloro-3-pyridinyl)-7-azabicyclo[2.2.1]heptane
0
3-Acetylnerbowdine
0
3-Epidemissidine
0
3-Epifortuneine
0
3-Epimacronine
0
3-Epischelhammericine
0
3-O-Acetylhamayne
0
4-(Methylthio)canthin-6-one
0
4-Hydroxycanthin-6-one
0
5-(Methylthio)canthin-6-one
0
5-Hydroxy-4-methoxy-3-methyl-2,6-canthinedione
0
5-Methoxycanthin-6-one
0
5-bromo-8-methoxy-1-methyl-beta-carboline
0
6,7-seco-Agroclavine
0
6-hydroxymanzamine A
0
7-Hydroxymitragynine
0
7-epi-cylindrospermopsin
0
8-Benzyl-9,10-dimethoxy-5,8-dihydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
0
8-Oxoerythraline_epoxide
0
8-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-1-hydroxy-5-methoxy-3-methyl-6-[(3S)-2-oxopiperidin-3-yl]-5H-benzo[b]phenanthridine-7,12-dione
0
8-hydroxymanzamine A
0
8-oxoerythraline
0
9-(Methylthio)canthin-6-one
0
9-O-Demethyl-2alpha-hydroxyhomolycorine
0
9-O-Demethylhomolycorine
0
9-deacetylfumigaclavine C
0
9-deoxycurtisin
0
Acutumidine
0
Acutumine
0
Affinine
0
Agroclavine I
0
Akuammine
0
Albomaculine
0
Alkaloid RC
0
Allopumiliotoxin 267a
0
Aloperine
0
Alpinine
0
Amalorin
0
Amatain
0
Ambelline
0
Ammothamnine
0
Anagyrine
0
Apovincamine
0
Argentine
0
Aristolactam AII
0
Aspidospermatine
0
Atherosperminine
0
Avenanthramide 1c
0
Avenanthramide 1p
0
Avenanthramide 2
0
Avenanthramide E
0
Baloxine
0
Baptifoline
0
Berberastine
0
Berberrubine
0
Bonafousine
0
Brovincamine fumarate
0
C-Curarine
0
Calebassone
0
Candimine
0
Capaurine
0
Caracurine V
0
Caribine
0
Caseadine
0
Catharanthine hcl
0
Catharanthine hemitartrate
0
Catharine
0
Caulophylline
0
Cavinine
0
Cevadine
0
Chanoclavine II
0
Cocculolidine
0
Coccutrine
0
Colchicoside
0
Coptisine chloride
0
Coreximine
0
Corynantheidine
0
Costaclavine
0
Crinamidine
0
Crinamine
0
Crinine
0
Cularicine
0
Cularidine
0
Cularimine
0
Cularine
0
Curtisin
0
Cycloclavine
0
D-Tetrahydropalmatine
0
Deacetylcolchicine
0
Decorticasine
0
Dehydrocorydaline
0
Dehydrocorydalmine
0
Dehydrocorytenchine
0
Delavine
0
Demissidine
0
Desmethylemetine
0
Didehydrostemofoline
0
Dihydrocorynantheine
0
Dihydrolycorine
0
Dihydrosetoclavine
0
Dimethamine
0
Dubiusine
0
Duguetine
0
Eburnamenin-14(15H)-one
0
Eburnamine
0
Eburnamonine
0
Elymoclavine
0
Epoxyagroclavine I
0
Erysonine
0
Erysothiopine
0
Erysotrine
0
Erythratidine
0
Erythratine
0
Erythrina alkaloid +
0
Fawcettidine
0
Floramultine
0
Fumigaclavine D
0
Fumigaclavine E
0
Fumigaclavine F
0
Fumigaclavine G
0
Fumigaclavine H
0
Gabunamine
0
Germerine
0
Germine
0
Glaudine
0
Glaziovine
0
Haemanthamine
0
Haemanthidine
0
Hamayne
0
Harringtonine
0
Hirsuteine
0
Homoormosanine
0
Imperialine
0
Isococculidine
0
Isomatrine
0
Isorheagenine
0
Jamine
0
Jatrorrhizine
0
Kreysigine
0
L-proline betaine
0
LSM-1309
0
LSM-1372
0
LSM-1597
0
LSM-16753
0
LSM-18556
0
LSM-1944
0
LSM-22634
0
LSM-24185
0
LSM-4236
0
LSM-4502
0
LSM-5249
0
LSM-6354
0
LSM-6387
0
LSM-6464
0
LSM-6667
0
Lambertine
0
Lycoflexine
0
Lycorenine
0
Matrine
0
Mecambrine
0
Methyl (15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
0
Methyl (1R,11S,17S)-12-ethylidene-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate
0
Methyl (1R,12S,20R)-12-ethyl-14-oxa-8,17-diazahexacyclo[10.7.1.01,9.02,7.013,15.017,20]icosa-2,4,6,9-tetraene-10-carboxylate
0
Methyl (1R,9S,11S,14E,15S,17S)-19-(acetyloxymethyl)-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.19,15.01,9.03,8.012,17]nonadeca-3,5,7-triene-19-carboxylate
0
Methyl (1S,10R,12R,19S)-12-ethyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
0
Methyl (1S,15E)-15-ethylidene-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate
0
Methyl (Z)-2-[(3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxyprop-2-enoate
0
Methyl 12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
0
Methyl 17-(1-hydroxyethyl)-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
0
Methyl 2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
Methyl 2-(3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
Methyl 2-(3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
N(4)-demethyl-12-methoxyalstogustine
0
N-(lysergyl-isoleucyl)-cyclo(phenylalanyl-prolyl)
0
N-Acetylcytisine
0
N-Acetylloline
0
N-Formyldemecolcine
0
N-Formylnorloline
0
N-Methyl-14-O-demethylepiporphyroxine
0
N-Methylcanadium (iodide)
0
N-Methylloline
0
N-[2-(3,4-diethoxyphenyl)ethyl]-4-phenoxybenzamide
0
N-acetylnorloline
0
N-formylloline
0
N-methylcheilanthifoline
0
N-methylnicotinate
0
N-methylphenylethanolamine
0
Nigerrimin B
0
Nobilisitine A
0
O-Methyllycorenine
0
Oxysophocarpine
0
Paliclavine
0
Panamine
0
Paspaclavine
0
Peimisine
0
Phellodendrine
0
Piperolactam A
0
Piperolactam C
0
Piperolactam D
0
Piptanthine
0
Pretazettine
0
Promucosine
0
Protoveratrine A
0
Protoveratrine B
0
Protoverine
0
Pseudocolumbamine
0
Pseudopalmatine
0
Psychotrin
0
Pumiliotoxin 251D
0
Pumiliotoxin A
0
Pyroclavine
0
Rhoeadine
0
Rhombifoline
0
Roquefortine A
0
Roxburghine B
0
Scholaricine
0
Serratanidine
0
Serratine
0
Sinactine
0
Sipeimine
0
Sophocarpine
0
Sophoranol
0
Spinosine
0
Tabernamine
0
Tabernanthine
0
Templetine
0
Thermospine
0
Tinctorine
0
Toxiferine I
0
Verticine
0
Vinpocetine
0
Worenine
0
Xylopinine
0
Zephyranthine
0
Zhebeinine
0
Zygadenine
0
[(6Ar,9R,10S,10aR)-7,9-dimethyl-5-(2-methylbut-3-en-2-yl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-10-yl] acetate
0
acetylcaranine
0
acremolin B
0
acronycine
0
ageladine A
1
alamarine
0
alkaloid antibiotic +
0
alkaloid ester +
0
angustilobine B, (rac)-
0
annomontine
0
ascidiathiazone A
0
ascidiathiazone B
0
aspernidine A
0
aspernigrin A +
0
asperparaline A
0
batzelladine A
0
batzelladine B
0
benzazepine alkaloid +
0
benzodiazepine alkaloid
0
beta,beta-ergoannam
0
beta-ergokryptam
0
beta-saxitoxinol(2+)
0
betalain +
0
biindole alkaloid +
0
bisindole alkaloid +
0
brovincamine
0
carbazole alkaloid +
0
carpaine
0
caulophine
0
ceratamine A
0
ceratamine B
0
cheilanthifoline
0
circumdatin H
0
colchicine +
1
coptisine
0
crambescidin 401
0
crambescidin 800
0
crambescidin 826
0
croomine
0
cryptopleurine
0
cylindrospermopsin
4
cystodytin D +
0
cystodytin E +
0
cystodytin F
0
cystodytin G
0
cytisine
0
cytochalasan alkaloid +
0
cytochalasin D
0
decahydroquinoline alkaloid +
0
decarbamoylsaxitoxin
0
deoxycylindrospermopsin
0
ent-6alpha-Hydroxybuphanisine
0
ent-6beta-Hydroxybuphanisine
0
epibatidine
0
ergoline alkaloid +
1
feruloylagmatine +
0
ficellomycin
0
glycoalkaloid +
0
gravacridonediol
0
harmala alkaloid +
0
hederacine A
0
hederacine B
0
herquline A
0
herquline B
0
herquline C
0
indirubin-3'-monoxime
0
indole alkaloid +
40
indolizidine alkaloid +
0
isoquinoline alkaloid +
1
karakoline
0
lamellarin alpha 20-hydrogen sulfate
0
leuconoxine
0
lycojapodine A
0
lycoperine A
0
lymphostin
0
manzamine A +
0
massadine
0
methyl (1S,12S,13E)-13-ethylidene-18-(hydroxymethyl)-4-methoxy-8,15-diazapentacyclo[10.5.1.01,9.02,7.010,15]octadeca-2(7),3,5,8-tetraene-18-carboxylate
0
monoamine alkaloid +
0
muscimol
0
neosaxitoxin
0
neotuberostemonine
0
nigerazine A
0
nigerazine B
0
nigragillin
0
nitensidine E
0
nostocarboline
0
oriciacridone C
0
oriciacridone F
0
oxyprotostemonine
0
paralytic shellfish toxin +
0
penipanoid B
0
phenanthrene alkaloid +
0
phenethylamine alkaloid +
0
phyllospadine
0
pipercallosidine
0
pipercallosine
0
piperidine alkaloid +
1
piperlactam S
0
protostemonine
0
pseudopelletierine
0
purine alkaloid +
1
pyridine alkaloid +
26
pyrrolidine alkaloid +
20
pyrrolizidine alkaloid +
2
pyrrolizine alkaloid +
0
pyrrolnitrin
0
quinazoline alkaloid +
0
quinoline alkaloid +
1
quinolizidine alkaloid +
0
rohitukine
0
ryanodine
2
sampangine
0
saxitoxin +
0
solanid-5-en-3-ol +
0
spermidine alkaloid +
0
spirosolane +
0
stemofoline
0
steroid alkaloid +
0
syncarpamide
0
terpene alkaloid +
0
tetrahydrocolumbamine
0
tetramethylpyrazine
0
thalictricavine
0
tropane alkaloid +
1
tuberostemonine
0
tuberostemonine N
0
undecylprodigiosin
0
veracevine
0
vinervine
0
xestospongin C
0
zarzissine
0
Path 2
CHEBI ontology
5066
subatomic particle
5057
composite particle
5057
hadron
5057
baryon
5057
nucleon
5057
atomic nucleus
5057
atom
5057
main group element atom
5026
main group molecular entity
5025
p-block molecular entity
5023
carbon group molecular entity
4940
organic molecular entity
4939
heteroorganic entity
4779
organonitrogen compound
382
alkaloid
74
(+)-Aspidospermidine
0
(+)-Erythraline
0
(+)-Norushinsunine N-oxide
0
(+)-Quebrachidine
0
(+)-Setoclavine
0
(+)-aplysinillin
0
(+/-)-gamma-Lycorane
0
(-)-12beta-Hydroxylsophocarpine
0
(-)-Alstolucine A, (rel)-
0
(-)-Alstolucine B, (rel)-
0
(-)-Alstolucine C
0
(-)-Alstolucine D, (rel)-
0
(-)-Alstolucine E
0
(-)-Alstolucine F
0
(-)-Apparicine
0
(-)-Ormosanine
0
(-)-Pyrifolidine
0
(-)-Quebrachamine
0
(-)-antofine
0
(-)-demecolcine
0
(-)-dibromophakellin
0
(13R,14E)-14-Ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene
0
(1R,1'R,10S,11S,12S,13'S,14'R)-12,14'-Diethylspiro[8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,8-tetraene-10,10'-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,12(21)-tetraene]
0
(1R,13S,14E,19S,21S)-10-[(1R,12S,13R,14E,17R,19S,21S)-14-Ethylidene-9-oxo-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,10-tetraen-17-yl]-14-(2-hydroxyethylidene)-8,16-diazahexacyclo[11.5.2.11,8.02,7.016,19.012,21]henicosa-2,4,6,11-tetraen-9-one
0
(1R,15R,17S)-17-Ethyl-6-[(1R,14R,15E)-15-ethylidene-17,18-dimethyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene
0
(1R,2R,12R,14S)-9-Methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraene-2,14-diol
0
(1R,2S,6S,11S,13R,14R,21R)-7,19,23-Triazahexacyclo[9.9.1.11,13.12,6.07,21.014,19]tricosane
0
(1R,9R)-5-Cyclohexyl-11-(propylsulfonyl)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one
0
(1S,15S,18S,19S,20S)-N-[2-(4-aminophenyl)ethyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
0
(1S,9R,10R,12S)-12-Hydroxy-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadeca-2,4-dien-6-one
0
(2'S)-Hydroxy-(11S,12R)-dihydrostemofoline, (rel)-
0
(2'S)-Hydroxystemofoline
0
(2R,3R,11Bs)-2-[(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinoline
0
(2R,3S,11bR)-2-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(2S,3R)-2-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(2S,3R)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine
0
(4aR,5aS,8aR,15bR)-10,11-dimethoxy-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one
0
(4aR,8aR,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one
0
(7S)-7-acetamido-1,2,3-trimethoxy-6,7-dihydro-5H-dibenzo[5,3-b:1',2'-e][7]annulene-9-carboxylic acid
0
(7S,14S)-(-)-7-Methyl-10-O-demethylxylopinine
0
(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethylhept-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol
0
(E)-Avenanthramide D
0
(R,S)-Scoulerine
0
(S)-1-hydroxy-N-methylcanadine +
0
(S)-colchicine
1
1',2'-didehydrostemofoline
0
1,2-O-Diacetylzephyranthine
0
1-O-Acetyllycorine
0
1-[(1R,9S,11R,12E,17S)-12-Ethylidene-10-(hydroxymethyl)-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6-trien-8-yl]ethanone
0
1-hydroxyprotostemonine, (rel)-
0
1-methoxy-5R,10S-agroclavine
0
10-alpha-methoxy-9,10-dihydrolysergol
0
11-(Methylthiono)canthin-6-one
0
11-Hydroxytubotaiwine
0
11-Hydroxyvittatine
0
11-Methoxyduguesuramine
0
11-Methoxysampangine
0
11-beta-hydroxy-beta-saxitoxinol(2+)
0
11-beta-hydroxysaxitoxin(2+)
0
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
0
13-O-Acetylbaptifoline
0
13-Oxocryptopine
0
14,15-Dehydro-16-epi-vincamine
0
14,19-Didehydrocondyfolan
0
14,19-Dihydroaspidospermatine
0
14-norpseurotin A
0
15-hydroxyangustilobine A
0
16-Ethoxystrychnine
0
16-Propoxystrychnine
0
16-epivincamine
0
16R,19E-isositsirikine
0
18-Epiormosanine
0
18-Hydroxy-11,17-dimethoxyyohimban-16-carboxylic acid
0
19,20-E-vallesamine
0
19-Acetyltabersonine
0
19-Hydroxytabersonine
0
2'-hydroxystemofoline
0
2,3,9,10-Tetrahydroxyberberine
0
2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline
0
2-(8-Oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)acetamide
0
2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide
0
2-Methoxycanthin-6-one
0
2-\{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino\}-5-hydroxybenzoic acid
0
2-phenylethylamine +
0
2-propylpiperidine
0
20(R)-tubotaiwine
0
20(S)-tubotaiwine
0
20-Epi-19,20-dihydro-decarbomethoxy vobasine
0
2alpha-(2'-pyrrolyl)-4alpha-methoxycarbonyl-5beta-[(2''-methyl)-heptyl]-1,3-oxazacyclohexane
0
3,4-dimethoxyphenylethylamine
0
3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol
0
3-(4-methoxyphenyl)-3-[[2-(4-methoxyphenyl)-1-oxoethyl]amino]propanoic acid
0
3-(6-chloro-3-pyridinyl)-7-azabicyclo[2.2.1]heptane
0
3-Acetylnerbowdine
0
3-Epidemissidine
0
3-Epifortuneine
0
3-Epimacronine
0
3-Epischelhammericine
0
3-O-Acetylhamayne
0
4-(Methylthio)canthin-6-one
0
4-Hydroxycanthin-6-one
0
5-(Methylthio)canthin-6-one
0
5-Hydroxy-4-methoxy-3-methyl-2,6-canthinedione
0
5-Methoxycanthin-6-one
0
5-bromo-8-methoxy-1-methyl-beta-carboline
0
6,7-seco-Agroclavine
0
6-hydroxymanzamine A
0
7-Hydroxymitragynine
0
7-epi-cylindrospermopsin
0
8-Benzyl-9,10-dimethoxy-5,8-dihydro-6H-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline
0
8-Oxoerythraline_epoxide
0
8-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-1-hydroxy-5-methoxy-3-methyl-6-[(3S)-2-oxopiperidin-3-yl]-5H-benzo[b]phenanthridine-7,12-dione
0
8-hydroxymanzamine A
0
8-oxoerythraline
0
9-(Methylthio)canthin-6-one
0
9-O-Demethyl-2alpha-hydroxyhomolycorine
0
9-O-Demethylhomolycorine
0
9-deacetylfumigaclavine C
0
9-deoxycurtisin
0
Acutumidine
0
Acutumine
0
Affinine
0
Agroclavine I
0
Akuammine
0
Albomaculine
0
Alkaloid RC
0
Allopumiliotoxin 267a
0
Aloperine
0
Alpinine
0
Amalorin
0
Amatain
0
Ambelline
0
Ammothamnine
0
Anagyrine
0
Apovincamine
0
Argentine
0
Aristolactam AII
0
Aspidospermatine
0
Atherosperminine
0
Avenanthramide 1c
0
Avenanthramide 1p
0
Avenanthramide 2
0
Avenanthramide E
0
Baloxine
0
Baptifoline
0
Berberastine
0
Berberrubine
0
Bonafousine
0
Brovincamine fumarate
0
C-Curarine
0
Calebassone
0
Candimine
0
Capaurine
0
Caracurine V
0
Caribine
0
Caseadine
0
Catharanthine hcl
0
Catharanthine hemitartrate
0
Catharine
0
Caulophylline
0
Cavinine
0
Cevadine
0
Chanoclavine II
0
Cocculolidine
0
Coccutrine
0
Colchicoside
0
Coptisine chloride
0
Coreximine
0
Corynantheidine
0
Costaclavine
0
Crinamidine
0
Crinamine
0
Crinine
0
Cularicine
0
Cularidine
0
Cularimine
0
Cularine
0
Curtisin
0
Cycloclavine
0
D-Tetrahydropalmatine
0
Deacetylcolchicine
0
Decorticasine
0
Dehydrocorydaline
0
Dehydrocorydalmine
0
Dehydrocorytenchine
0
Delavine
0
Demissidine
0
Desmethylemetine
0
Didehydrostemofoline
0
Dihydrocorynantheine
0
Dihydrolycorine
0
Dihydrosetoclavine
0
Dimethamine
0
Dubiusine
0
Duguetine
0
Eburnamenin-14(15H)-one
0
Eburnamine
0
Eburnamonine
0
Elymoclavine
0
Epoxyagroclavine I
0
Erysonine
0
Erysothiopine
0
Erysotrine
0
Erythratidine
0
Erythratine
0
Erythrina alkaloid +
0
Fawcettidine
0
Floramultine
0
Fumigaclavine D
0
Fumigaclavine E
0
Fumigaclavine F
0
Fumigaclavine G
0
Fumigaclavine H
0
Gabunamine
0
Germerine
0
Germine
0
Glaudine
0
Glaziovine
0
Haemanthamine
0
Haemanthidine
0
Hamayne
0
Harringtonine
0
Hirsuteine
0
Homoormosanine
0
Imperialine
0
Isococculidine
0
Isomatrine
0
Isorheagenine
0
Jamine
0
Jatrorrhizine
0
Kreysigine
0
L-proline betaine
0
LSM-1309
0
LSM-1372
0
LSM-1597
0
LSM-16753
0
LSM-18556
0
LSM-1944
0
LSM-22634
0
LSM-24185
0
LSM-4236
0
LSM-4502
0
LSM-5249
0
LSM-6354
0
LSM-6387
0
LSM-6464
0
LSM-6667
0
Lambertine
0
Lycoflexine
0
Lycorenine
0
Matrine
0
Mecambrine
0
Methyl (15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
0
Methyl (1R,11S,17S)-12-ethylidene-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2,4,6,9-tetraene-10-carboxylate
0
Methyl (1R,12S,20R)-12-ethyl-14-oxa-8,17-diazahexacyclo[10.7.1.01,9.02,7.013,15.017,20]icosa-2,4,6,9-tetraene-10-carboxylate
0
Methyl (1R,9S,11S,14E,15S,17S)-19-(acetyloxymethyl)-14-ethylidene-18-oxa-2,12-diazahexacyclo[9.6.1.19,15.01,9.03,8.012,17]nonadeca-3,5,7-triene-19-carboxylate
0
Methyl (1S,10R,12R,19S)-12-ethyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
0
Methyl (1S,15E)-15-ethylidene-12-oxo-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate
0
Methyl (Z)-2-[(3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxyprop-2-enoate
0
Methyl 12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
0
Methyl 17-(1-hydroxyethyl)-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate
0
Methyl 2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
Methyl 2-(3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
Methyl 2-(3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
0
N(4)-demethyl-12-methoxyalstogustine
0
N-(lysergyl-isoleucyl)-cyclo(phenylalanyl-prolyl)
0
N-Acetylcytisine
0
N-Acetylloline
0
N-Formyldemecolcine
0
N-Formylnorloline
0
N-Methyl-14-O-demethylepiporphyroxine
0
N-Methylcanadium (iodide)
0
N-Methylloline
0
N-[2-(3,4-diethoxyphenyl)ethyl]-4-phenoxybenzamide
0
N-acetylnorloline
0
N-formylloline
0
N-methylcheilanthifoline
0
N-methylnicotinate
0
N-methylphenylethanolamine
0
Nigerrimin B
0
Nobilisitine A
0
O-Methyllycorenine
0
Oxysophocarpine
0
Paliclavine
0
Panamine
0
Paspaclavine
0
Peimisine
0
Phellodendrine
0
Piperolactam A
0
Piperolactam C
0
Piperolactam D
0
Piptanthine
0
Pretazettine
0
Promucosine
0
Protoveratrine A
0
Protoveratrine B
0
Protoverine
0
Pseudocolumbamine
0
Pseudopalmatine
0
Psychotrin
0
Pumiliotoxin 251D
0
Pumiliotoxin A
0
Pyroclavine
0
Rhoeadine
0
Rhombifoline
0
Roquefortine A
0
Roxburghine B
0
Scholaricine
0
Serratanidine
0
Serratine
0
Sinactine
0
Sipeimine
0
Sophocarpine
0
Sophoranol
0
Spinosine
0
Tabernamine
0
Tabernanthine
0
Templetine
0
Thermospine
0
Tinctorine
0
Toxiferine I
0
Verticine
0
Vinpocetine
0
Worenine
0
Xylopinine
0
Zephyranthine
0
Zhebeinine
0
Zygadenine
0
[(6Ar,9R,10S,10aR)-7,9-dimethyl-5-(2-methylbut-3-en-2-yl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-10-yl] acetate
0
acetylcaranine
0
acremolin B
0
acronycine
0
ageladine A
1
alamarine
0
alkaloid antibiotic +
0
alkaloid ester +
0
angustilobine B, (rac)-
0
annomontine
0
ascidiathiazone A
0
ascidiathiazone B
0
aspernidine A
0
aspernigrin A +
0
asperparaline A
0
batzelladine A
0
batzelladine B
0
benzazepine alkaloid +
0
benzodiazepine alkaloid
0
beta,beta-ergoannam
0
beta-ergokryptam
0
beta-saxitoxinol(2+)
0
betalain +
0
biindole alkaloid +
0
bisindole alkaloid +
0
brovincamine
0
carbazole alkaloid +
0
carpaine
0
caulophine
0
ceratamine A
0
ceratamine B
0
cheilanthifoline
0
circumdatin H
0
colchicine +
1
coptisine
0
crambescidin 401
0
crambescidin 800
0
crambescidin 826
0
croomine
0
cryptopleurine
0
cylindrospermopsin
4
cystodytin D +
0
cystodytin E +
0
cystodytin F
0
cystodytin G
0
cytisine
0
cytochalasan alkaloid +
0
cytochalasin D
0
decahydroquinoline alkaloid +
0
decarbamoylsaxitoxin
0
deoxycylindrospermopsin
0
ent-6alpha-Hydroxybuphanisine
0
ent-6beta-Hydroxybuphanisine
0
epibatidine
0
ergoline alkaloid +
1
feruloylagmatine +
0
ficellomycin
0
glycoalkaloid +
0
gravacridonediol
0
harmala alkaloid +
0
hederacine A
0
hederacine B
0
herquline A
0
herquline B
0
herquline C
0
indirubin-3'-monoxime
0
indole alkaloid +
40
indolizidine alkaloid +
0
isoquinoline alkaloid +
1
karakoline
0
lamellarin alpha 20-hydrogen sulfate
0
leuconoxine
0
lycojapodine A
0
lycoperine A
0
lymphostin
0
manzamine A +
0
massadine
0
methyl (1S,12S,13E)-13-ethylidene-18-(hydroxymethyl)-4-methoxy-8,15-diazapentacyclo[10.5.1.01,9.02,7.010,15]octadeca-2(7),3,5,8-tetraene-18-carboxylate
0
monoamine alkaloid +
0
muscimol
0
neosaxitoxin
0
neotuberostemonine
0
nigerazine A
0
nigerazine B
0
nigragillin
0
nitensidine E
0
nostocarboline
0
oriciacridone C
0
oriciacridone F
0
oxyprotostemonine
0
paralytic shellfish toxin +
0
penipanoid B
0
phenanthrene alkaloid +
0
phenethylamine alkaloid +
0
phyllospadine
0
pipercallosidine
0
pipercallosine
0
piperidine alkaloid +
1
piperlactam S
0
protostemonine
0
pseudopelletierine
0
purine alkaloid +
1
pyridine alkaloid +
26
pyrrolidine alkaloid +
20
pyrrolizidine alkaloid +
2
pyrrolizine alkaloid +
0
pyrrolnitrin
0
quinazoline alkaloid +
0
quinoline alkaloid +
1
quinolizidine alkaloid +
0
rohitukine
0
ryanodine
2
sampangine
0
saxitoxin +
0
solanid-5-en-3-ol +
0
spermidine alkaloid +
0
spirosolane +
0
stemofoline
0
steroid alkaloid +
0
syncarpamide
0
terpene alkaloid +
0
tetrahydrocolumbamine
0
tetramethylpyrazine
0
thalictricavine
0
tropane alkaloid +
1
tuberostemonine
0
tuberostemonine N
0
undecylprodigiosin
0
veracevine
0
vinervine
0
xestospongin C
0
zarzissine
0